Regeneron has received a second complete response letter from the FDA for odronextamab and anticipates delays for Eylea HD ...

Qure (NASDAQ:QURE) is one of the biotech stocks to buy according to Wall Street analysts. Earlier on June 2, uniQure provided a regulatory update on AMT-130, which is the company’s investigational ...

Gain insights from Ocugen's Q2 2025 earnings call, highlighting clinical advancements, strategic partnerships, BLA milestones for 2026-2027, and ...

Q2 2025 Management View CEO Matthew Kapusta highlighted that "the first half of 2025 has been tremendously productive for the company as we advance AMT-130 towards potentially becoming the first ...

The report highlights the extreme brutality of some BLA attacks, citing the hijacking of the Jaffar Express in Balochistan on ...

“On 11 March, BLA hijacked the Jaffar Express train in an isolated mountainous region with improvised explosive devices and ...

The United Nations Security Council report pointed out that "some BLA attacks showed a high degree of complexity and brutality", citing Jaffar Express' dramatic hijacking in Pakistan's Balochistan ...

While the BLA’s funding sources remain unclear, analysts suggest multiple revenue streams, including illicit activities such as extortion, smuggling and drug trafficking.

San Diego Padres outfielder Fernando Tatis Jr. filed a legal complaint Monday against Big League Advance Fund and Big League Advantage, LLC (BLA), a company that offers players upfront payments in ...